Cargando…

Correction: Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents

Detalles Bibliográficos
Autores principales:	Lahmann, Carolina, Kramer, Holger B., Ashcroft, Frances M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472889/ https://www.ncbi.nlm.nih.gov/pubmed/30998784 http://dx.doi.org/10.1371/journal.pone.0215989

Ejemplares similares

Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents
por: Lahmann, Carolina, et al.
Publicado: (2015)

Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti‑B7H3 immunotherapy
por: Kramer, Kim, et al.
Publicado: (2021)

Correction to: Q&A: insulin secretion and type 2 diabetes: why do β-cells fail?
por: Cantley, James, et al.
Publicado: (2019)

Correction: Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
Publicado: (2014)

Correction: Increased Interleukin-17 in Peripheral Blood and Cerebrospinal Fluid of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2015)

Correction to: Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
por: Lee, Bongyong, et al.
Publicado: (2022)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
por: Visser, Pieter Jelle, et al.
Publicado: (2022)

Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”
Publicado: (2023)

Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation
por: Alshora, Doaa, et al.
Publicado: (2023)

2546. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels
por: Kane, Nicholas, et al.
Publicado: (2023)

Author Correction: In vivo assessment of cerebrospinal fluid efflux to nasal mucosa in humans
por: Melin, Erik, et al.
Publicado: (2023)

Correction to: A26 Cerebrospinal fluid outflow resistance is increased following small-moderate ischaemic stroke
por: Patabendige, Adjanie, et al.
Publicado: (2019)

Correction to: Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease
por: Signoriello, Elisabetta, et al.
Publicado: (2021)

Correction: Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
por: Orlovska-Waast, Sonja, et al.
Publicado: (2019)

Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: De Kort, Anna M., et al.
Publicado: (2021)

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer’s disease
por: Herden, Janne Marieke, et al.
Publicado: (2023)

Author Correction: Quantifying the relationship between spreading depolarization and perivascular cerebrospinal fluid flow
por: Mukherjee, Saikat, et al.
Publicado: (2023)

Correction: Youssef et al. Glibenclamide Nanocrystal-Loaded Bioactive Polymeric Scaffolds for Skin Regeneration: In Vitro Characterization and Preclinical Evaluation. Pharmaceutics 2021, 13, 1469
por: Youssef, Julie R., et al.
Publicado: (2023)

Correction: Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease
por: Schmidt, Frank M., et al.
Publicado: (2013)

Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés‐Benito, Pol, et al.
Publicado: (2021)

Correction: Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs
por: Liu, Wei, et al.
Publicado: (2022)

Author Correction: A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
por: Xiang, Chunchen, et al.
Publicado: (2023)

Cerebrospinal fluid solute transport associated with sensorimotor brain activity in rodents
por: Kim, Evgenii, et al.
Publicado: (2023)

Correction: Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis
Publicado: (2014)

Correction: Clinical Evaluation of a Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Neisseria meningitidis in Cerebrospinal Fluid
Publicado: (2015)

Correction: Soluble Toll-Like Receptors 2 and 4 in Cerebrospinal Fluid of Patients with Acute Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage
por: Sokół, Bartosz, et al.
Publicado: (2016)

Correction: A Proteomic Analysis of Individual and Gender Variations in Normal Human Urine and Cerebrospinal Fluid Using iTRAQ Quantification
por: Guo, Zhengguang, et al.
Publicado: (2019)

Correction: Neural activity induced by sensory stimulation can drive large-scale cerebrospinal fluid flow during wakefulness in humans
por: Williams, Stephanie D., et al.
Publicado: (2023)

Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
por: Siafarikas, Nikias, et al.
Publicado: (2022)

Correction: Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
Publicado: (2014)

Correction to: Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
por: Groveman, Bradley R., et al.
Publicado: (2020)

Correction: The Role of Aerobic Fitness in Cortical Thickness and Mathematics Achievement in Preadolescent Children
por: Chaddock-Heyman, Laura, et al.
Publicado: (2015)

Correction: Intestinal Tumorigenesis Is Not Affected by Progesterone Signaling in Rodent Models
por: Heijmans, Jarom, et al.
Publicado: (2013)

Correction: Rodent-borne infections in rural Ghanaian farming communities
por: Nimo-Paintsil, Shirley C., et al.
Publicado: (2019)

Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
por: Morieri, Mario Luca, et al.
Publicado: (2022)

Evaluation of Trigonella foenum-graecum extract in combination with swimming exercise compared to glibenclamide consumption on type 2 Diabetic rodents
por: Arshadi, Sajad, et al.
Publicado: (2015)

Interaction of Herbs and Glibenclamide: A Review
por: Rai, Amita, et al.
Publicado: (2012)

Glibenclamide for the Treatment of Ischemic and Hemorrhagic Stroke
por: Caffes, Nicholas, et al.
Publicado: (2015)

Glibenclamide Prevents Diabetes in NOD Mice
por: Lamprianou, Smaragda, et al.
Publicado: (2016)

Glibenclamide for the Treatment of Acute CNS Injury
por: Kurland, David B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ocqqsvnerlejrsisi3b646oufj